Expansion and functional maturation of human tumor antigen-specific CD8+ T Cells after vaccination with antigenic peptide

Clinical Cancer Research

Volumn 7, Issue 11 SUPPL., 2001, Pages

  Pittet, Mikaël J ^a   Speiser, Daniel E ^a   Liénard, Danielle ^a   Valmori, Danila ^a   Guillaume, Philippe ^a   Dutoit, Valérie ^a   Rimoldi, Donata ^b   Lejeune, Ferdy ^a   Cerottini, Jean Charles ^a,b   Romero, Pedro ^a,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Hopital Orthopedique de la Suisse Romande   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; GAMMA INTERFERON; GRANZYME; GZMB PROTEIN, HUMAN; MART1 ANTIGEN; MONOCLONAL ANTIBODY; PEPTIDE; SERINE PROTEINASE; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; CD8+ T LYMPHOCYTE; CELL DIVISION; CHEMISTRY; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; LYMPHOCYTE; MELANOMA; METABOLISM; NEOPLASM; PHENOTYPE; TIME;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; FLOW CYTOMETRY; GRANZYMES; HUMANS; INTERFERON TYPE II; LYMPHOCYTES; MELANOMA; NEOPLASM PROTEINS; NEOPLASMS; PEPTIDES; PHENOTYPE; SERINE ENDOPEPTIDASES; TIME FACTORS;

EID: 0035290621     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Coulie, P. G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., Renauld, J. C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
2. Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., and Rosenberg, S. A. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA, 91: 3515-3519, 1994.
3. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
4. Romero, P., Gervois, N., Schneider, J., Escobar, P., Valmori, D., Pannetier, C., Steinle, A., Wölfel, T., Liénard, D., Brichard, V., Van Pel, A., Jotereau, F., and Cerottini, J-C. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. J. Immunol., 159: 2366-2374, 1997.
5. Romero, P., Dunbar, P. R., Valmori, D., Pittet, M. J., Ogg, G. S., Rimoldi, D., Chen, J. L., Liénard, D., Cerottini, J-C., and Cerundolo, V. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med., 188: 1641-1650, 1998.
6. Pittet, M. J., Valmori, D., Dunbar, P. R., Speiser, D., Liénard, D., Lejeune, F., Fleischhauer, K., Cerundolo, V., Cerottini, J-C., and Romero, P. High frequencies of naive Melan-A/MART-1-specific CD8+ T cells in a large proportion of HLA-A2 individuals. J. Exp. Med., 190: 705-716, 1999.
7. Lee, P. P., Yee, C., Savage, P. A., Fong, L., Brockstedt, D., Weber, J. S., Johnson, D., Swetter, S., Thompson, J., Greenberg, P. D., Roederer, M., and Davis, M. M. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med., 5: 677-685, 1999.
8. Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., and Blum, R. H. Interferon α-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J. Clin. Oncol., 14: 7-17, 1996.
9. Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., and Davis, M. M. Phenotypic analysis of antigen-specific T lymphocytes. Science (Washington DC), 274: 94-96, 1996.
10. Valmori, D., Fonteneau, J. F., Marañón Lizana, C., Gervois, N., Liénard, D., Rimoldi, D., Jongeneel, C. V., Jotereau, F., Cerottini, J-C., and Romero, P. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogs. J. Immunol., 160: 1750-1758, 1998.
11. Men, Y., Miconnet, I., Valmori, D., Rimoldi, D., Cerottini, J-C., and Romero, P. Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice. J. Immunol., 162: 3566-3573, 1999.
12. Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., and Moretta, L. Major histocompatibility complex class 1-specific receptors on human natural killer and T lymphocytes. Immunol. Rev., 155: 105-117, 1997.
13. Colonna, M., Navarro, F., Bellon, T., Llano, M., Garcia, P., Samaridis, J., Angman, L., Cella, M., and Lopez-Botet, M. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med., 186: 1809-1818, 1997.
14. Nakajima, H., Cella, M., Langen, H., Friedlein, A., and Colonna, M. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol., 29: 1676-1683, 1999.
15. Lee, K. H., Wang, E., Nielsen, M. B., Wunderlich, J., Migueles, S., Connors, M., Steinberg, S. M., Rosenberg, S. A., and Marincola, F. M. Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J. Immunol., 163: 6292-6300, 1999.
16. Ogg, G. S., Dunbar, P. R., Romero, P., Chen, J. L., and Cerundolo, V. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med., 188: 1203-1208, 1998.
17. Azuma, M., Phillips, J. H., and Lanier, L. L. CD28-T lymphocytes. Antigenic and functional properties. J. Immunol., 150: 1147-1159, 1993.
18. Bell, E. B., Sparshott, S. M., and Bunce, C. CD4+ T-cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol. Today, 19: 60-64, 1998.
19. Hamann, D., Baars, P. A., Rep, M. H., Hooibrink, B., Kerkhof-Garde, S. R., Klein, M. R., and van Lier, R. A. Phenotypic and functional separation of memory and effector human CD8+ T cells. J. Exp. Med., 186: 1407-1418, 1997.
20. Wang, E. C., Moss, P. A., Frodsham, P. M., Lehner, P. J., Bell, J. I., and Borysiewicz, L. K. CD8high CD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. J. Immunol., 155: 5046-5056, 1995.
21. Pittet, M. J., Speiser, D. E., Valmori, D., Cerottini, J. C., and Romero, P. Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J. Immunol., 164: 1148-1152, 2000.
22. Speiser, D. E., Pittet, M. J., Valmori, D., Dunbar, P. R., Rimoldi, D., Liénard, D., MacDonald, H. R., Cerottini, J-C., Cerundolo, V., and Romero, P. In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. J. Exp. Med., 190: 775-782, 1999.
23. Valmori, D., Dutoit, V., Liénard, D., Rimoldi, D., Pittet, M. J., Champagne, P., Ellefsen, K., Sahin, U., Speiser, D., Lejeune, F., Cerottini, J-C., and Romero, P. Naturally occurring HLA-A2 restricted CD8+ T cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Cancer Res., 60: 4499-4506, 2000.
24. Valmori, D., Pittet, M. J., Vonarbourg, C., Rimoldi, D., Liénard, D., Speiser, D., Dunbar, R., Cerundolo, V., Cerottini, J-C., and Romero, P. Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. Cancer Res., 59: 4050-4055, 1999.
25. Jäger, E., Nagata, Y., Gnjatic, S., Wada, H., Stockert, E., Karbach, J., Dunbar, P. R., Lee, S. Y., Jungbluth, A., Jäger, D., Arand, M., Ritter, G., Cerundolo, V., Dupont, B., Chen, Y-T., Old, L. J., and Knuth, A. Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc. Natl. Acad. Sci. USA, 97: 4760-4765, 2000.
26. Salgaller, M. L., Afshar, A., Marincola, F. M., Rivoltini, L., Kawakami, Y., and Rosenberg, S. A. Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides. Cancer Res., 55: 4972-4979, 1995.
27. Jäger, E., Ringhoffer, M., Arand, M., Karbach, Jäger, D., Ilsemann, C., Hagedorn, M., Oesch, F., and Knuth, A. Cytolytic T cell reactivity against melanoma-associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma Res., 6: 419-425, 1996.
28. Valmori, D., Pittet, M. J., Rimoldi, D., Liénard, D., Dunbar, R., Cerundolo, V., Lejeune, F., Cerottini, J-C., and Romero, P. An antigen targeted approach to adoptive transfer therapy of cancer. Cancer Res., 59: 2167-2173, 1999.
29. + cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo. Int. J. Cancer, 66: 470-476, 1996.
30. Ferrone, S., and Marincola, F. M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 16: 487-494, 1995.
31. Onrust, S. V., Hartl, P. M., Rosen, S. D., and Hanahan, D. Modulation of L-selectin ligand expression during an immune response accompanying tumorigenesis in transgenic mice. J. Clin. Investig., 97: 54-64, 1996.
32. Speiser, D. E., Miranda, R., Zakarian, A., Bachmann, M. F., McKall-Faienza, K., Odermatt, B., Hanahan, D., Zinkernagel, R. M., and Ohashi, P. S. Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J. Exp. Med., 186: 645-653, 1997.
33. Zinkernagel, R. M., and Hengartner, H. Antiviral immunity. Immunol. Today, 18: 258-260, 1997.
34. Murali-Krishna, K., Altman, J. D., Suresh, M., Sourdive, D. J., Zajac, A. J., Miller, J. D., Slansky, J., and Ahmed, R. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity, 8: 177-187, 1998.
35. Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., and Rickinson, A. B. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J. Exp. Med., 187: 1395-1402, 1998.